Search

everythinglearnresearchcommunity

for

Search:↓

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The study found that the enzyme linked to acne is present in the same areas of both acne-affected and normal skin.

Type 2 5α-reductase plays a key role in hair loss.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

Androgenetic alopecia is common hair loss due to genetics and DHT.

5AR inhibitors like finasteride and dutasteride improve hair growth and slow hair loss in male pattern baldness.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Overexpression of COX-2 causes early hair loss in mice, but can be prevented with a COX-2 inhibitor.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The compound 4c effectively inhibits the enzyme linked to hair loss.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.